Login to access your membership accounts, education training and products and services.
Designed specifically for the experienced regulatory professional, the RAPS Executive Development program builds key management, business and leadership skills through intense discussions with some of the world’s best business professors in an intimate learning environment at the Kellogg School of Management.
Evanston, IL6/8/2015 - 6/11/2015
RAPS Virtual Career Fairs are designed to connect employees with employers no matter where they might be located.
Local or global—RAPS has you covered with offices in Washington, DC, Shanghai and Singapore. There are RAPS chapters in Canada, Israel, Switzerland, Taiwan and throughout the United States, and local networks in Australia, Belgium, Brazil, Germany, India, Mexico, The Netherlands, Poland and Singapore.
Placeholder for Higher Logic Forum Discussions - DO NOT DELETE
An analysis of the impact of FDA’s four expedited programs on
development and review of drugs for serious conditions over the last two-and-a-half
years since breakthrough therapy designation was introduced, including a
RAPS’ next Virtual Career Fair is planned for Thursday, 18 June 2015, from 12 to 4:30 pm EDT. The event allows regulatory job seekers the opportunity to chat live in an interactive virtual environment with hiring managers and recruiters from top healthcare organizations looking to fill regulatory openings.
We're taking some time off next week. Find out when you can get your fix of Focus again here.
Regulatory Focus is pleased to team with Tarius, a regulatory information services provider, to routinely offer insight about upcoming FDA Scientific Advisory Committee (SAC) meetings for CDER, CBER, and the Office of the Commissioner.
Subscribe to RSS
Sign up for regular emails from RAPS. We'll never share your info and you can unsubscribe any time.
The US House Energy and Commerce (E&C) Committee has released an updated draft of a piece of legislation which proposes dramatically overhauling the way in which the US Food and Drug Administration (FDA) regulates many healthcare products. View More
An updated draft of the House Energy and Commerce (E&C) Committee's 21st Century Cures Act has reintroduced a provision which would extend marketing exclusivity for some drugs repurposed to treat rare diseases or conditions by six months. View More
Regulatory Focus is pleased to team with Tarius, a regulatory information services provider, to routinely offer insight about upcoming FDA Scientific Advisory Committee (SAC) meetings for CDER, CBER, and the Office of the Commissioner. View More
Since early 2014, more than 20 states have introduced so-called "Right to Try" bills in the hopes of allowing terminally ill patients to access experimental—and potentially life-saving—treatments more easily. These bills are modeled off a federal policy known as "Compassionate Use," but contain several key changes meant to make it faster and easier for patients to obtain experimental therapies. View More